Genomic Predictors of Outcome in Prostate Cancer.


CONTEXT Given the highly variable behavior and clinical course of prostate cancer (PCa) and the multiple available treatment options, a personalized approach to oncologic risk stratification is important. Novel genetic approaches offer additional information to improve clinical decision making. OBJECTIVE To review the use of genomic biomarkers in the… (More)
DOI: 10.1016/j.eururo.2015.04.008


4 Figures and Tables

Slides referencing similar topics